(Total Views: 234)
Posted On: 01/04/2021 4:15:48 PM
Post# of 28

$KLDO News Article - Kaleido Biosciences Announces Completion of Enrollment of 350 Subjects in Controlled Study of KB109 in the Treatment of Mild-to-Moderate COVID-19 https://marketwirenews.com/news-releases/kale...75150.html


My Twitter: WhyteStocks